CD24 gene allele variation is not associated with oligoclonal IgG bands and IgG index of multiple sclerosis patients

NeuroImmunoModulation

Volumn 19, Issue 3, 2012, Pages 195-199

  Saadatnia, Mohammad ^a,b,c,d   Najafi, Mohammad Reza ^a,d   Najafi, Faride ^d   Davoudi, Vahid ^a,b,d   Keyhanian, Kiandokht ^a,b,d   Maghzi, Amir Hadi ^a,d,e  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

CD24 gene; Genetics; Immunology; Multiple sclerosis; Oligoclonal IgG band

Indexed keywords

CD24 ANTIGEN; IMMUNOGLOBULIN G; OLIGOCLONAL BAND;

ADULT; ALLELE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE SEQUENCE; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS SEVERITY SCORE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM;

ADULT; ALLELES; ANTIGENS, CD24; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; IMMUNOGLOBULIN G; MALE; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS;

EID: 84855874607     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000332011     Document Type: Article

References (36)

1. Brassat D: Pathophysiology of multiple sclerosis (in French). Presse Med 2010; 39: 341-348.
2. Gay FW, Dry TJ, Dick GWA, Esiri MM: The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Brain 1997; 120: 1461-1483.
3. Genian CP, Cannella B, Hauser SL, Rain CS: Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 1999; 5: 170-175. (Pubitemid 29068523)
4. Andersson M, Alvarez-Carmeno J, Bernardi G, Cogato I, Fredman P, Frederiksen J, et al: Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 1994; 57: 897-902. (Pubitemid 24251050)
5. Stendahl-Brodin L, Link H: Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1980; 43: 102-105. (Pubitemid 10129581)
6. Zeman AZ, Kidd D, McLean BN, Kelly MA, Francis DA, Miller DH, et al: A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 60: 27-30. (Pubitemid 26013190)
7. Siritho S, Freedman MS: The prognostic significance of cerebrospinal fluid in multiple sclerosis. J Neurol Sci 2009; 279: 21-25.
8. Farrell MA, Kaufmann JCE, Gilbert JJ, Noseworthy JH, Armstrong HA, Ebers GC: Oligoclonal bands in multiple sclerosis: clinicopathologic correlation. Neurology 1985; 35: 212-218. (Pubitemid 15171520)
9. Oksenberg JR, Barcellos LF: Multiple sclerosis genetics: leaving no stone unturned. Genes Immun 2005; 6: 375-387. (Pubitemid 43090513)
10. Ebers G: Modelling multiple sclerosis. Nat Genet 1999; 23: 258-259. (Pubitemid 29526415)
11. Haines JL, Ter-Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H, et al: A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet 1996; 13: 469-471. (Pubitemid 26256623)
12. Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER, et al: Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum Mol Genet 1998; 7: 1229-1234. (Pubitemid 28383054)
13. Kenealy SJ, Herrel LA, Bradford Y, Schnetz-Boutaud N, Oksenberg JR, Hauser SL, et al: Examination of seven candidate regions for multiple sclerosis: strong evidence of linkage to chromosome 1q44. Genes Immun 2006; 7: 73-76.
14. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, et al: A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996; 13: 464-468. (Pubitemid 26256622)
15. Sawcer S, Ban M, Maranian M, Yeo TW, Compston A, Kirby A, et al: A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 2005; 77: 454-67. (Pubitemid 41192651)
16. Kikuchi S, Fukazawa T, Niio M, Yabe I, Miyagishi R, Hamada T: HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Neurology 2003; 60: 647-651. (Pubitemid 36246084)
17. Barcellos LF, Oksenberg JR, Green AJ, Bucher P, Rimmler JB, Schmidt S, et al: Genetic basis for clinical expression in multiple sclerosis. Brain 2002; 125: 150-158. (Pubitemid 34084044)
18. Goris A, Maranian M, Walton A, Yeo TW, Ban M, Gray J, et al: CD24 Ala/Val polymorphism and multiple sclerosis. J Neuroimmunol 2006; 175: 200-202. (Pubitemid 43765737)
19. Zhou Q, Rammoha K, Lin S, Robinson N, Li O, Liu X, et al: CD24 is a genetic modifier for risk and progression of multiple sclerosis. Proc Natl Acad Sci USA 2003; 102: 15041-15046. (Pubitemid 37518013)
20. Bai XF, Liu JQ, Liu X, Guo Y, Cox K, Wen J, Zheng P, Liu Y: The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis. J Clin Invest 2000; 105: 1227-1232. (Pubitemid 30266075)
21. Saadatnia M, Etemadifar M, Maghzi AH: Multiple sclerosis in Isfahan, Iran. Int Rev Neurobiol 2007; 79: 357-375.
22. McDonald WI, Compston A, Edan G., Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
23. Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, et al: Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144-1151.
24. Walker RW, Keir G, Johnson MH, Thompson EJ: A rapid method for detecting oligoclonal IgG in unconcentrated CSF by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining. J Neuroimmunol 1983; 4: 141-148. (Pubitemid 13134764)
25. Sá MJ, Sequeira L, Rio ME, Thompson EJ: Oligoclonal IgG bands in the cerebrospinal fluid of Portuguese patients with multiple sclerosis: negative results indicate benign disease. Arq Neuropsiquiatr 2005; 63: 375-379. (Pubitemid 40942361)
26. Izquierdo G, Angulo S, Garcia-Moreno JM, Gamero MA, Navarro G, Gata JM, et al: Intrathecal IgG synthesis: marker of progression in multiple sclerosis patients. Acta Neurol Scand 2002; 105: 158-163. (Pubitemid 34258955)
27. El-Salem K, Al-Shimmery E, Horany K, Al-Refai A, Al-Hayk K, Khader Y: Multiple sclerosis in Jordan: a clinical and epidemiological study. J Neurol 2006; 253: 1210-1216. (Pubitemid 44511480)
28. Tanaka K, Kujuro Y, Suzuki S, Tanahashi N, Hamada J, Nogawa S, et al: Clinical and laboratory features of in-patients with multiple sclerosis in a University Hospital in Tokyo from 1988-2002. Intern Med 2005; 44: 560-566. (Pubitemid 40932828)
29. Yamasaki K, Horiuchi I, Minohara M, Kawano Y, Ohyagi Y, Yamada T, et al: HLADPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 1999; 122: 1689-1696. (Pubitemid 29425672)
30. Tsai CP, Yuan CL, Yu HY, Chen C, Guo YC, Shan DE: Multiple sclerosis in Taiwan. J Chin Med Assoc 2004; 67: 500-505. (Pubitemid 40069082)
31. Correale J, de los Milagros Bassani M: Oligoclonal bands and antibody responses in multiple sclerosis. J Neuroimmunol 2002; 249: 375-389. (Pubitemid 34304609)
32. Ronaghi M, Vallian S, Etemadifar M: CD24 gene polymorphism is associated with the disease progression and susceptibility to multiple sclerosis in the Iranian population. Psychiatry Res 2009; 170: 271-272.
33. Bai XF, Li O, Zhou Q, Zhang H, Joshi P, Zheng X, et al: CD24 controls expansion and persistence of autoreactive T cells in the central nervous system during experimental autoimmune encephalomyelitis. J Exp Med 2004; 200: 447-458. (Pubitemid 39121902)
34. Goertsches R, Villoslada P, Comabella M, Montalban X, Navarro A, De La Concha EG, et al: A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the disease. J Neuroimmunol 2003; 143: 124-128. (Pubitemid 37324299)
35. Fernald GH, Yeh RF, Hauser SL, Oksenberg JR, Baranzini SE: Mapping gene activity in complex disorders: integration of expression and genomic scans for multiple sclerosis. J Neuroimmunol 2005; 167: 157-169. (Pubitemid 41244806)
36. Otaegui D, Sáenz A, Camaño P, Blázquez L, Goicoechea M, Ruíz-Martínez J, et al: CD24 V/V is an allele associated with the risk of developing multiple sclerosis in the Spanish population. Mult Scler 2006; 12: 511-514. (Pubitemid 44132594)